CLASS II Drug recall · Reported 4 Jul 2018 · FDA Enforcement Report

fentanyl Citrate USP 5 mcg in 9% Sodium Chloride recalled

Advanced Pharma is recalling fentanyl Citrate USP 5 mcg in 9% Sodium Chloride USP, 10 mcg per mL prefilled syringe, distributed in Texas. The recall was initiated on 20 Jun 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 6/12/18 0432 149-21072S, BUD 9/10/18
Quantity recalled100 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0889-2018
FDA event ID
80354
Recalling firm
Advanced Pharma, Houston, TX
Classification
Class II
Status
Terminated
Recall initiated
20 Jun 2018
FDA classified
25 Jun 2018
Reported
4 Jul 2018
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Potency & Assay
Drug class
Pain Medication

Timeline

20 Jun 2018Recall initiated by company
25 Jun 2018Classified by FDA+5 days
4 Jul 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX 77054, NDC 15082-210-72.

Where it was distributed

Distributed to one medical center in Fort Worth, TX.

Texas

Questions about this recall

Is fentanyl Citrate USP 5 mcg in 9% Sodium Chloride USP, 10 mcg per mL prefilled syringe recalled?

Yes. Advanced Pharma recalled fentanyl Citrate USP 5 mcg in 9% Sodium Chloride USP, 10 mcg per mL prefilled syringe on 20 Jun 2018. The recall is Class II and its status is Terminated. Recall number D-0889-2018.

Why was it recalled?

Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.

Which lots are affected?

Lot #: 6/12/18 0432 149-21072S, BUD 9/10/18

Where was it sold?

Distributed to one medical center in Fort Worth, TX.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Advanced Pharma

All 99

Other Fentanyl recalls

All 21